Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,174 across all filing types
Latest filing 2024-10-09 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Intimation regarding loss of share certificate by the shareholders.
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, concerning the loss of share certificates. It is addressed to stock exchanges and signed by the company secretary. The content is a formal regulatory compliance communication about shareholder share certificate loss details, not a financial report or announcement of voting results, management changes, or capital changes. It is a regulatory filing related to compliance with listing obligations. The document length is short (2778 characters) and contains no financial data or report content. Therefore, it fits best under Regulatory Filings (RNS).
2024-10-09 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2024. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialisation of securities and related compliance. The document is addressed to stock exchanges and is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. The document length is 3385 characters, which is relatively short and consistent with a certification or attestation letter. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and not a full report or announcement of financial results or corporate actions.
2024-10-07 English
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended on September 30, 2024.
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2024. It is addressed to stock exchanges and includes a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialisation of securities. The document is short (3388 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or other report content. It is a regulatory filing confirming compliance with a specific regulation.
2024-10-07 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the completion of a U.S. FDA Pre-Approval Inspection at the company's biotech facility. It is an announcement of a regulatory event rather than a financial report or detailed filing. The document is short (1854 characters) and serves as a regulatory update without financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-05 English
U.S. FDA Inspection of the Company''s Biotech Facility in Pune.
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the completion of a U.S. FDA Pre-Approval Inspection at the company's biotech facility. It is an announcement of an event related to regulatory compliance and inspection results, not a full report or detailed financial document. The document length is short (1854 characters) and it serves as a regulatory update rather than a detailed report or financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-10-05 English
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 95% confidence The document is a compliance certificate submitted under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the loss of share certificates for a shareholder. The content is a regulatory compliance filing related to share certificate loss, not a financial report, earnings release, or management information. It is a formal regulatory filing to stock exchanges. The document length is short and it does not contain financial data or report results. Therefore, it fits best under Regulatory Filings (RNS) as a general compliance announcement.
2024-10-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.